Upregulation of nuclear PA28γ expression in cirrhosis and hepatocellular carcinoma

Experimental and Therapeutic Medicine

Volumn 3, Issue 3, 2012, Pages 379-385

  Kondo, Motoi ^a   Moriishi, Kohji ^b   Wada, Hiroshi ^c   Noda, Takehiro ^c   Marubashi, Shigeru ^c   Wakasa, Kenichi ^d   Matsuura, Yoshiharu ^b   Doki, Yuichiro ^c   Mori, Masaki ^c   Nagano, Hiroaki ^c  

^a Evidence Based Medical Research Center   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Immunohistochemistry; Proteasome activator 28 ; Western blotting

Indexed keywords

PROTEASOME ACTIVATOR 28GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FATTY LIVER; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

EID: 84855846618     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.415     Document Type: Article

References (24)

1. Montalto G, Cervello M, Giannitrapani L, Dantona F, TerranovaA and Castagnetta LA: Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 963: 13-20, 2002.
2. Okuda K: Hepatocellular carcinoma: Recent progress. Hepatology15: 948-963, 1992.
3. Kew MC and Popper H: Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis 4: 136-146, 1984.
4. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, ChayamaK, KumadaH and Kawanishi M. A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology18: 47-53, 1993.
5. Shiratori Y, Shiina S, Imamura M, et al: Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology 22: 1027-1033, 1995.
6. Nagasue N, Uchida M, Makino Y, et al: Incidence and factors associated with intrahepatic recurrence following resection of hepatocellular carcinoma. Gastroenterology 105: 488-494, 1993.
7. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, KumadaH, WatanabeG and Tsurumaru M: Risk factors for tumor recur- rence and prognosis after curative resection of hepatocellular carcinoma. Cancer 71: 19-25, 1993.
8. Shimada M, Takenaka K, Gion T, et al: Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology 111: 720-726, 1996.
9. Kumada T, Nakano S, Takeda I, et al: Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology25: 87-92, 1997.
10. Moriishi K, Mochizuki R, Moriya K, et al: Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis. Proc Natl Acad Sci USA 104: 1661-1666, 2007.
11. Myers J, Mehta P, Hunter AW, Bernstein SA and EricksonPA. Automated double-label immunohistochemistry. J Surg Pathol 1: 105-113, 1995.
12. Chretien S, Dubart A, Beaupain D, et al: Alternative transcrip- tion and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. Proc Natl Acad Sci USA 85: 6-10, 1988.
13. Nagel S, Schmidt M, Thiede C, Huhn D and Neubauer A: Quantification of Bcr-Abl transcripts in chronic myelogenous leukemia (CML) using standardized, internally controlled, competitive differential PCR (CD-PCR). Nucleic Acids Res 24: 4102-4103, 1996.
14. Kim KH, Hong SP, Kim K, Park MJ, Kim KJ and Cheong J: HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 355: 883-888, 2007.
15. Finke J, Fritzen R, Ternes P, Lange W and Dolken G: An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. Biotechniques 14: 448-453, 1993.
16. Sasaki Y, Imaoka S, Fujita M, et al: Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma. Ann Surg. 206: 40-47, 2007.
17. Ko S, Nakajima Y, Kanehiro H, et al: Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Result of multivariate analysis. Ann Surg 224: 591-595, 1996.
18. Sasaki Y, Imaoka S, Masutani S, Ohashi I, Ishikawa O, KoyamaH and Iwanaga T: Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 112: 515-21, 1992.
19. Okamura T, Taniguchi S, Ohkura T, et al: Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. J Clin Endocrinol Metab 88: 1374-1383, 2003.
20. El-Assal ON, Yamanoi A, Soda Y, et al: Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27: 1554-1562, 1998.
21. Raedle J, Oremek G, Truschnowitsch M, Lorenz M, RothWK, Caspary WF and Zeuzem S: Clinical evaluation of autoanti- bodies to p53 protein in patients with chronic liver disease and hepatocellular carcinoma. Eur J Cancer 34: 1198-1203, 1998.
22. Kishimoto Y, Shiota G, Kamisaki Y, et al: Loss of the tumor suppressor p53 gene at the liver cirrhosis stage in Japanese patients with hepatocellular carcinoma. Oncology 54: 304-310, 1997.
23. Tarao K, Takemiya S, Tamai S, et al: Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitisC virus-associated cirrhosis and HCC. Cancer 79: 688-694, 1997.
24. Ko S, Nakajima Y, Kanehiro H, et al: Influence of associated viral hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. World J Surg 21: 1082-1086, 1996.